Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Vlassara

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
Blood Purification|January 1, 1994
Serum advanced glycosylation end products: a new class of uremic toxins?H Vlassara
Diabetes Care|November 1, 1990
Chronic diabetic complications and tissue glycosylation. Relevant concern for diabetes-prone black populationH Vlassara
Blood Purification|January 1, 1995
Advanced glycosylation endproducts in diabetic renal disease: clinical measurement, pathophysiological significance, and prospects for pharmacological inhibitionR Bucala, H Vlassara
Diabetes|July 1, 1996
Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptorsH Vlassara, R Bucala
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1995
Advanced glycosylation end products in diabetic renal and vascular diseaseR Bucala, H Vlassara
Journal of Internal Medicine|March 22, 2002
Diabetes and advanced glycation endproductsH Vlassara, M R Palace
Diabetes|July 1, 1983
Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasminM Brownlee, H Vlassara, A Cerami
Diabetes|September 1, 1986
Trapped immunoglobulins on peripheral nerve myelin from patients with diabetes mellitusM Brownlee, H Vlassara, A Cerami
Diabetes|December 1, 1990
Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7S Radoff, A Cerami, H Vlassara
Clinical Chemistry|October 1, 1986
Nonenzymatic glycosylation: role in the pathogenesis of diabetic complicationsH Vlassara, M Brownlee, A Cerami
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Blood Purification|January 1, 1994
Serum advanced glycosylation end products: a new class of uremic toxins?H Vlassara
Diabetes Care|November 1, 1990
Chronic diabetic complications and tissue glycosylation. Relevant concern for diabetes-prone black populationH Vlassara
Blood Purification|January 1, 1995
Advanced glycosylation endproducts in diabetic renal disease: clinical measurement, pathophysiological significance, and prospects for pharmacological inhibitionR Bucala, H Vlassara
Diabetes|July 1, 1996
Recent progress in advanced glycation and diabetic vascular disease: role of advanced glycation end product receptorsH Vlassara, R Bucala
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|December 1, 1995
Advanced glycosylation end products in diabetic renal and vascular diseaseR Bucala, H Vlassara
Journal of Internal Medicine|March 22, 2002
Diabetes and advanced glycation endproductsH Vlassara, M R Palace
Diabetes|July 1, 1983
Nonenzymatic glycosylation reduces the susceptibility of fibrin to degradation by plasminM Brownlee, H Vlassara, A Cerami
Diabetes|September 1, 1986
Trapped immunoglobulins on peripheral nerve myelin from patients with diabetes mellitusM Brownlee, H Vlassara, A Cerami
Diabetes|December 1, 1990
Isolation of surface binding protein specific for advanced glycosylation end products from mouse macrophage-derived cell line RAW 264.7S Radoff, A Cerami, H Vlassara
Clinical Chemistry|October 1, 1986
Nonenzymatic glycosylation: role in the pathogenesis of diabetic complicationsH Vlassara, M Brownlee, A Cerami
Pageof 12